Your browser doesn't support javascript.
loading
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia.
Gu, Yongquan; Cui, Shijun; Wang, Qi; Liu, Changjian; Jin, Bi; Guo, Wei; Liu, Changwei; Chu, Tongbin; Shu, Chang; Zhang, Fuxian; Han, Chengquan; Liu, Yue.
Afiliação
  • Gu Y; Vascular Surgery Department, Xuan Wu Hospital, Capital Medical University, Beijing, China. Electronic address: 15901598209@163.com.
  • Cui S; Vascular Surgery Department, Xuan Wu Hospital, Capital Medical University, Beijing, China.
  • Wang Q; Vascular Surgery Department, First Hospital, Jilin University, Changchun, China.
  • Liu C; Vascular Surgery Department, Nanjing Drum Tower Hospital, Nanjing, China.
  • Jin B; Vascular Surgery Department, Wuhan Union Hospital, Wuhan, China.
  • Guo W; Vascular Surgery Department, Chinese PLA General Hospital, Beijing, China.
  • Liu C; Vascular Surgery Department, Peking Union Medical College Hospital, Beijing, China.
  • Chu T; Diabetic Foot Treatment Center, Second Hospital of Dalian Medical University, Dalian, China.
  • Shu C; Vascular Surgery Department, Second Xiang Ya Hospital, Central South University, Changsha, China.
  • Zhang F; Vascular Surgery Department, Shi Ji Tan Hospital, Capital Medical University, Beijing, China.
  • Han C; R&D Center of Beijing Northland Biotech. Co., Ltd., China.
  • Liu Y; R&D Center of Beijing Northland Biotech. Co., Ltd., China.
Mol Ther ; 27(12): 2158-2165, 2019 12 04.
Article em En | MEDLINE | ID: mdl-31805256

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmídeos / Terapia Genética / Fator de Crescimento de Hepatócito / Isquemia / Perna (Membro) Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmídeos / Terapia Genética / Fator de Crescimento de Hepatócito / Isquemia / Perna (Membro) Idioma: En Ano de publicação: 2019 Tipo de documento: Article